Global private equity and venture capital news and research

Posts Tagged ‘biotech’

13 April 2015

Biotech sees second month of declining investment from PE, VC firms $

venbio_sq.jpg Private equity and venture capital investment activity targeting the global biotechnology sector declined in March for the second month in a row, new research shows.

12 March 2015

Biotech PE, VC value up on 2015 despite monthly value drop $

lab petri life science clinic The value of private equity, venture capital and development capital investment targeting global biotechnology companies fell by 48 per cent in February compared to the previous month despite a year-on-year gain.

2 March 2015

VC-backed biotech business Canbex to be bought for €96m

lab petri life science clinic Venture capital-backed UK biotech business Canbex Therapeutics has agreed to be bought by Ipsen in a €96m deal.

10 February 2015

Weak start to the year for global biotech investment value $

biotech virus lab The value of private equity, venture capital and development capital investment in the global biotechnology sector decreased in January compared to the previous month despite a rise in volume. A total of $455m was invested in biotech companies over the four weeks, down 82 per cent from a high base of $2.58bn in December according to[...]

9 January 2015

Sofinnova Ventures hires biotech veteran Welch as executive partner

Dan W_1420698769 Life sciences investor Sofinnova Ventures has hired former biotech CEO Daniel Welch as executive partner.

6 January 2015

Pfizer leads $20m Series C round in CytomX to fight cancer

health Pfizer Venture Investments has led a $20m Series C financing round in biotech firm CytomX.

27 November 2014

Idinvest seals 7.6x return exiting Prosensa through $680m buyout

Prosensa Idinvest Partners has made a 7.6-times return by exiting its stake in Dutch biotechnology business Prosensa in a deal which values the business at $680m.

11 November 2014

Parter Capital leads $4.6m Series A for Swiss biotech company

more-money-1207333-m A consortium of Swiss private investors known as Partner Capital Group has led a CHF4.5m ($4.6m) financing round for stem cell research company Histide.

5 November 2014

Clarus leads $26.5m round in biotech company Imago BioSciences

lab-751198-m Global venture capital firm Clarus Ventures has led a $26.5m Series A financing round in biotechnology firm Imago BioSciences.

8 October 2014

Waterland in talks to buy Median from Advent and Marcol

biotech lab clinic research Dutch private equity group Waterland is reportedly in talks to buy German clinic chain Median Kliniken from Advent and Marcol in a deal worth $1.26bn.

Page 1 of 1112345...10...Last »

Legals & Terms of UsePrivacy Policy

AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: Zetland House, 5-25 Scrutton St, London EC2A 4HJ
Content is © AltAssets 2000-2015